黑质网状部PV+神经元组胺H2受体双向调控冒险行为
该研究在小鼠中揭示黑质网状部(SNr)小清蛋白阳性(PV+)神经元上的组胺H2受体(H2R)双向调控冒险行为;H2R缺陷通过改变PV+神经元动态及上丘投射功能促进冒险,而药理学激活SNr H2R可挽救DAT+/-小鼠的过度冒险探索。
要点
- SNr PV+神经元H2R双向调控小鼠冒险行为。
- H2R缺陷通过改变PV+神经元动态及上丘投射促进冒险。
- 激活SNr H2R可挽救DAT+/-小鼠过度冒险探索。
核心结论
- SNr PV+神经元H2R缺陷通过破坏PV+神经元功能及其下游投射驱动小鼠冒险行为执行。
- H2R可能是病理性冒险行为的潜在治疗靶点。
研究设计与样本
- 研究采用小鼠模型,结合H2R缺陷、PV+神经元动态记录及药理学激活实验。
- 使用DAT+/-小鼠作为ADHD样表型伴冒险行为增加的模型。
主要发现
- SNr PV+神经元H2R双向调控冒险行为。
- 上丘投射的SNr PV+神经元功能障碍导致H2R缺陷引起的冒险增加。
- H2R缺陷以H2R依赖方式改变风险评估期间PV+神经元动态而促进冒险。
- 药理学激活SNr H2R可挽救DAT+/-小鼠的过度冒险探索。
临床怎么用
- H2R可能作为病理性冒险行为的潜在治疗靶点,尤其与ADHD相关冒险行为。
- SNr PV+神经元及上丘投射通路可作为干预冒险行为的神经环路靶点。
局限性
- 研究为小鼠实验,结论向人类精神疾病转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Risk-taking is frequently observed in psychiatric conditions such as attention-deficit hyperactivity disorder, yet the neuronal mechanisms underlying this behavior remain unclear. Here, we show that histamine H2 receptor (H2R) in parvalbumin-positive neurons (PV+) of the substantia nigra pars reticulata (SNr) bidirectionally regulates risk-taking behaviors. Dysfunction of superior colliculus-projecting SNr PV+ neurons contributes to the increased risk-taking caused by H2R deficiency. Moreover, H2R deficiency promotes risk-taking behavior by altering PV+ neuronal dynamics during risk assessment in an H2R-dependent manner. Pharmacological activation of H2R in the SNr rescues excessive risky exploration in dopamine transporter heterozygous mutant mice (DAT+/-), a well-established mouse model of attention deficit hyperactivity disorder (ADHD)-like phenotypes with increased risk-taking behavior. Collectively, these findings demonstrate that H2R deficiency in SNr PV+ neurons drives risk-taking execution by disrupting the function of PV+ neurons and their downstream projections in mice. It may enhance the understanding of the neural mechanism underlying threat-related risk-taking and highlight H2R as a potential therapeutic target for pathological risk-taking behavior.
引用
- An D, Zheng L, Zhu J, et al. Histamine H2 receptor in substantia nigra pars reticulata parvalbumin positive neurons mediates risk-taking behavior. Mol Psychiatry. 2026. PMID: 42763339. doi:10.1038/s41380-026-03892-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。